Literature DB >> 19703385

[Does acidosis in brain play a role in Alzheimer's disease?].

Michael Pirchl1, Christian Humpel.   

Abstract

Alzheimer's disease is characterized by beta-amyloid plaques, tau pathology, cell death of cholinergic neurons, inflammatory processes and cerebrovascular damage. The reasons for the development of this chronic disease are not known yet. We hypothesize that chronic long lasting mild damage of the cerebrovascular brain capillaries cause hypoperfusion, acidosis and neurodegeneration, and induces a cell death cascade with beta-amyloid dysfunction and tau-pathology and inflammation. Vascular risk factors, such as hyperhomocysteinemia or hypercholesterolemia, may play a role in this process. The accumulation of chronic silent strokes may cause cognitive defects as seen in vascular dementia and Alzheimer's disease. This summary tries to link the different events, which occur in Alzheimer's disease, focusing on the cerebrovascular hypothesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703385

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  11 in total

Review 1.  Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.

Authors:  Heeyoung Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2020-09-09       Impact factor: 4.946

2.  Zinc transporter 10 (ZnT10)-dependent extrusion of cellular Mn2+ is driven by an active Ca2+-coupled exchange.

Authors:  Moshe Levy; Nadav Elkoshi; Shiran Barber-Zucker; Eitan Hoch; Raz Zarivach; Michal Hershfinkel; Israel Sekler
Journal:  J Biol Chem       Date:  2019-02-12       Impact factor: 5.157

3.  Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.

Authors:  Mirela Dobre; Sarah A Gaussoin; Jeffrey T Bates; Michel B Chonchol; Debbie L Cohen; Thomas H Hostetter; Kalani L Raphael; Addison A Taylor; Alan J Lerner; Jackson T Wright; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-22       Impact factor: 8.237

Review 4.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

5.  Role of pH in structural changes for Pin1 protein: an insight from molecular dynamics study.

Authors:  Yu Wang; Lei Xi; Jie Yao; Jiao Yang; Lin-Fang Du
Journal:  J Mol Model       Date:  2014-07-17       Impact factor: 1.810

Review 6.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.

Authors:  Zhentao Zhang; Manling Xie; Keqiang Ye
Journal:  Expert Opin Ther Targets       Date:  2016-05-13       Impact factor: 6.902

7.  Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.

Authors:  Gustavo Basurto-Islas; Inge Grundke-Iqbal; Yunn Chyn Tung; Fei Liu; Khalid Iqbal
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

Review 8.  Heart failure and Alzheimer's disease.

Authors:  P Cermakova; M Eriksdotter; L H Lund; B Winblad; P Religa; D Religa
Journal:  J Intern Med       Date:  2014-08-01       Impact factor: 8.989

9.  Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.

Authors:  Zhentao Zhang; Mingke Song; Xia Liu; Seong Su Kang; Il-Sun Kwon; Duc M Duong; Nicholas T Seyfried; William T Hu; Zhixue Liu; Jian-Zhi Wang; Liming Cheng; Yi E Sun; Shan Ping Yu; Allan I Levey; Keqiang Ye
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

10.  Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states.

Authors:  Elfriede Dall; Julia C Hollerweger; Sven O Dahms; Haissi Cui; Katharina Häussermann; Hans Brandstetter
Journal:  J Biol Chem       Date:  2018-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.